GGrantIndex
Sort

23,748 grants matching melanoma

(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity

$518,165
Nir Hacohen · Broad Institute, Inc. · R01 · FY2016 · CA

(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity

$518,165
Nir Hacohen · Broad Institute, Inc. · R01 · FY2017 · CA

(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity

$518,165
Nir Hacohen · Broad Institute, Inc. · R01 · FY2018 · CA

Project 2: Targeting differentiation-linked redox sensitivity in melanoma

$517,922
Thomas G Graeber · University Of California Los Angeles · P01 · FY2020 · CA

Project 2: Targeting differentiation-linked redox sensitivity in melanoma

$517,922
Thomas G Graeber · University Of California Los Angeles · P01 · FY2021 · CA

Project 1: Strategies to enhance MEK inhibitor efficacy in MUTNRAS melanoma

$517,920
Roger S Lo · University Of California Los Angeles · P01 · FY2021 · CA

Project 3: Modeling and overcoming resistance to melanoma immunotherapy

$517,920
Antoni Ribas · University Of California Los Angeles · P01 · FY2021 · CA

Project 3: Modeling and overcoming resistance to melanoma immunotherapy

$517,920
Antoni Ribas · University Of California Los Angeles · P01 · FY2020 · CA

Project 1: Strategies to enhance MEK inhibitor efficacy in MUTNRAS melanoma

$517,920
Roger S Lo · University Of California Los Angeles · P01 · FY2020 · CA

Indoor Tanning Use, DNA Repair and Risk of Melanoma

$517,781
Deann Lazovich · University Of Minnesota · R01 · FY2007 · CA

Mechanisms of UVA-induced skin cancer

$517,763
Yu-Ying He · University Of Chicago · R01 · FY2011 · ES

TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE

$517,756
Harvard University (Medical School) · R01 · FY2004 · EB

CDKN2A couples lipid metabolism to ferroptosis in glioblastoma

$517,754
David A. Nathanson · University Of California Los Angeles · R01 · FY2023 · NS

Adrenocortical Cancer and Thyroid Carcinomas: Models with Unique Properties

$517,626
Antonio Fojo · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Immunophysiological Mechanisms in the Biological Therapy of Cancer

$517,622
Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Ultrasonic perfusion imaging of peripheral vascular disease

$517,547
Michael F Insana · University Of Illinois At Urbana-Champaign · R01 · FY2022 · HL

An integrated polymeric carrier for subunit cancer vaccines

$517,545
Suzie H Pun · University Of Washington · R01 · FY2025 · CA

Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound

$517,432
Richard J Price · University Of Virginia · R01 · FY2018 · CA

(PQ8) Patient- and tumor-specific biomarkers and mechanisms that predict irAEs resulting from checkpoint inhibition

$517,415
Justin M Balko · Vanderbilt University Medical Center · R01 · FY2021 · CA

(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitors

$517,329
Anton Wellstein · Georgetown University · R01 · FY2019 · CA

Proton-coupled folate/antifolate transport

$517,054
Israel David Goldman · Albert Einstein College Of Medicine · R01 · FY2011 · CA

MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER

$516,975
Marco Ruella · University Of Pennsylvania · R37 · FY2023 · CA

NG2-PG in tumor vascularization and progression

$516,950
Burnham Institute For Medical Research · R01 · FY2003 · CA

Tissue Resident memory T cell responses to cancer

$516,944
Mary J Turk · Dartmouth College · R01 · FY2019 · CA

A Tailored Internet Intervention for Skin Cancer Risk Reduction in Young Adults

$516,733
Carolyn J. Heckman · Research Inst Of Fox Chase Can Ctr · R01 · FY2013 · CA